Altendorf K, Epstein W, Löhmann A
J Bacteriol. 1986 Apr;166(1):334-7. doi: 10.1128/jb.166.1.334-337.1986.
Transport systems for K+ in Escherichia coli are not detectable in membrane vesicles, but vesicles will take up K+ (and Rb+) in the presence of valinomycin. It is generally believed that valinomycin acts as a lipid-soluble cation carrier and that it does not interact with or activate cation transport systems. This view is challenged by Bhattacharyya et al. (Proc. Natl. Acad. Sci. USA 68:1448-1492, 1971), who reported reduced uptake in vesicles from E. coli mutants with K+ transport defects. We reexamined this question with some of the same mutants and were unable to confirm a correlation of valinomycin-induced vesicle transport with transport properties in intact cells. We found great variability in transport activity of vesicles from these E. coli K-12 strains and believe such variability as well as possible contamination with intact cells accounts for the earlier report. Our data do not support the idea that valinomycin-mediated transport in vesicles is related to physiological K+ transport systems.
在大肠杆菌中,钾离子的转运系统在膜泡中无法检测到,但在缬氨霉素存在的情况下,膜泡会摄取钾离子(和铷离子)。人们普遍认为缬氨霉素作为一种脂溶性阳离子载体,并不与阳离子转运系统相互作用或激活阳离子转运系统。这一观点受到了Bhattacharyya等人(《美国国家科学院院刊》68:1448 - 1492, 1971)的质疑,他们报道来自具有钾离子转运缺陷的大肠杆菌突变体的膜泡摄取减少。我们用一些相同的突变体重新审视了这个问题,却无法证实缬氨霉素诱导的膜泡转运与完整细胞中的转运特性之间存在关联。我们发现这些大肠杆菌K - 12菌株的膜泡转运活性存在很大差异,并认为这种差异以及可能存在的完整细胞污染是早期报告的原因。我们的数据不支持缬氨霉素介导的膜泡转运与生理性钾离子转运系统相关的观点。